PI
RCKT icon

Putnam Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

Putnam Investments’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$32.1M Buy
1,069,715
+70,466
+7% +$1.56M 0.04% 169
2023
Q3 		$20.5M Buy
999,249
+202,324
+25% +$3.68M 0.03% 204
2023
Q2 		$15.8M Buy
796,925
+168,411
+27% +$3.4M 0.02% 243
2023
Q1 		$10.8M Buy
628,514
+406,514
+183% +$7.96M 0.02% 296
2022
Q4 		$4.34M Buy
+222,000
New +$4.09M 0.01% 473
2021
Q3 		– Sell
-188,698
Closed -$8.36M – 821
2021
Q2 		$8.36M Hold
188,698
– – 0.01% 413
2021
Q1 		$8.37M Sell
188,698
-143,445
-43% -$7.88M 0.01% 409
2020
Q4 		$18.2M Buy
332,143
+68,501
+26% +$2.5M 0.03% 261
2020
Q3 		$6.03M Sell
263,642
-159,995
-38% -$3.94M 0.01% 442
2020
Q2 		$8.87M Buy
423,637
+80,637
+24% +$1.45M 0.02% 355
2020
Q1 		$4.79M Buy
343,000
+136,600
+66% +$2.7M 0.01% 447
2019
Q4 		$4.7M Buy
+206,400
New +$3.45M 0.01% 519
2017
Q1 		– Sell
-8,630
Closed -$211K – 1276
2016
Q4 		$211K Buy
8,630
+112
+1% +$3.2K ﹤0.01% 1223
2016
Q3 		$323K Sell
8,518
-11,176
-57% -$351K ﹤0.01% 1172
2016
Q2 		$586K Sell
19,694
-112
-0.6% -$3.94K ﹤0.01% 1175
2016
Q1 		$586K Buy
19,806
+68
+0.3% +$2.04K ﹤0.01% 1216
2015
Q4 		$895K Sell
19,738
-751
-4% -$32.7K ﹤0.01% 1182
2015
Q3 		$771K Buy
+20,489
New +$941K ﹤0.01% 1231

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Putnam Investments's RCKT Position: Q4 2023 in Review

Putnam Investments increased its Rocket Pharmaceuticals (RCKT) stake by 7.1% in Q4 2023, buying an estimated $1.56M and bringing the position to 1,069,715 shares worth $32.1M. The position accounts for 0.04% of the portfolio, ranked #169.

Putnam Investments first reported a position in RCKT in Q3 2015 and has held it in 18 quarters since. 194 funds tracked by Wall St. Rank hold RCKT as of Q4 2023.

  • Putnam Investments held 1,069,715 shares of Rocket Pharmaceuticals worth $32.1M as of Q4 2023.
  • Putnam Investments bought 70,466 Rocket Pharmaceuticals shares in Q4 2023, an estimated $1.56M.
  • Rocket Pharmaceuticals made up 0.04% of Putnam Investments's portfolio in Q4 2023, its #169 holding.
  • Putnam Investments first reported a position in Rocket Pharmaceuticals in Q3 2015 and has held it in 18 quarters since.
  • 194 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.